Business Development – Page 2

27Aug 2021 by ggarciadme@gmail.com

Biotech: The American El Dorado

Business

By Juan Rivera-Mata, Ph. D. Markentry USA Partner. Pfizer in the first 6 months of 2021 obtained US $1,330 million in profits (+62% compared to the first half of 2020). This was mainly due to the sale of more than 1 billion COVID-19 vaccines. But the discovery of the vaccine came from BioNTech, a German company of 2 Turkish researchers. In the same period, BioNtech got 2,800 million euros in profit, while in the first 6 months of 2020 it had losses of 141.7 million euros; it was the first time they have had a profit. With the current contracts and the expected recommendation of a third booster dose, BioNtech will probably end 2021 as one of the world's leading pharmaceutical companies, similar to Biogen, Teva or Novo-Nordisk, a company…

21Jul 2021 by ggarciadme@gmail.com

US Travel Bans: News and Expectations

Blog

What are the travel bans currently applicable to citizens of certain countries when coming to the US? What recent changes have taken place? What is their impact? Why are they maintained? What evolution can we expect? In this article we try to answer these questions. 1) Status As is well known, since January 2020, the US government has been imposing a series of entry bans on travelers from a group of countries as a result of the pandemic caused by COVID-19. These bans, which have hardly changed and currently affect 33 countries, prevent entry when the traveler has been in one of them in the previous 14 days. The countries affected are, in chronological order of their ban, China, Iran, the Schengen Area, the United Kingdom, Ireland, Brazil, South Africa…

28May 2021 by ggarciadme@gmail.com

Keys for the Commercialization of Medical Devices in the US

Laws and regulations

By Maria Jose Lopez Barragan, Ph.D. Markentry USA Partner and Juan Rivera-Mata, Ph. D. Markentry USA Partner Many companies plan their entry into the American market without a good understanding of the legal requirements that govern their products in the US. The FDA (Food and Drug Administration) regulates the consumption not only of drugs and food, but also of veterinary products, cosmetics, tobacco, and so-called “medical devices”.About one-fifth of what American consumers spend is, in one way or another, regulated by the FDA Under the category of medical devices there is a wide variety of products that ranges from complex devices that assist robotic surgery or even artificial organs, to objects that accompany our daily lives and whose perception can be very different from what anyone would consider a medical…

24May 2021 by ggarciadme@gmail.com

How to Ensure your International Company Website is Effective in the US

Business Development

Introduction At this point, it should be unnecessary to explain why taking care of the online presence of a business is essential if you want to succeed in any market in the world, with very few exceptions. However, it is surprising the high number of errors that can be identified when reviewing the web pages of international companies that are devoting large amounts of resources to entering the US market. In this article we will identify the most frequent problems and propose some ways to solve them.Think Globally, Act LocallyIn a global or international strategy, it is essential to know the details that must be adapted for important markets. The United States is a country with special characteristics that may lead to the need for not obvious modifications in the message…

24Feb 2021 by ggarciadme@gmail.com

Seven deadly sins in US market entry

Business

By Gonzalo Garcia, Founder and CEO of Markentry USA CONTENTS Introduction 1. Not adapting the 4 Ps of the ‘marketing mix’ to the target market 2. Ignoring regional differences or acting in the wrong state 3. Landing without the local support of experts in the target market 4. Acting without a subsidiary or choosing an inappropriate structure for it 5. Designing a complex and rigid business plan 6. Underestimating costs and deadlines 7. Underestimating the impact the US can have on the business Conclusion Conclusion Introduction The challenge faced by international companies and foreign entrepreneurs when trying to enter the US market is as great as the payoff obtained from succeeding. We are talking about a market of 330 million people with a per capita income of $65,000, which being…

28Oct 2020 by ggarciadme@gmail.com

Biopharma perspectives 2021-24 with Trump or Biden

Business Development

By Juan Rivera-Mata, Markentry USA Partner The US elections may entail different scenarios for the biopharmaceutical industry. During his term, Trump has tried to eliminate “Obamacare” (a law that, among other things, makes it mandatory for companies to provide health insurance to their employees), and Biden has used that possibility as a main element of his campaign. But, at the same time as the President, local and state officials are also elected, and the House of Representatives and 1/3 of the Senate are renewed. It appears that Democrats will remain a majority in the House, but the Senate, now Republican, may go "blue." Trump has appointed 3 members of the Supreme Court - for life -, making it (6/3) conservative. The obligation to have health insurance (and any subsequent reform) will…

29Sep 2020 by ggarciadme@gmail.com

The «Dunning-Kruger» effect and the importance of feasibility studies in business internationalization to the US market

Strategy

By Gonzalo Garcia, Founder and CEO of Markentry USA 1. The Dunning-Kruger effect and other cognitive biases The Argentinian actor Ricardo Darín, in the fabulous film "The secret in their eyes", awarded an Oscar for the best foreign film, defined in an anthological scene two types of idiots: the one who knows he is an idiot and is therefore harmless, and the one who thinks he is a genius and does nothing but generate problems. The truth is that we are all exposed to behaving like both kinds of idiots in many fields, as modern psychology has amply shown. This is the "Dunning-Kruger" effect, discovered by social psychologists David Dunning and Justin Kruger, which is defined as the inability to recognize our own ineptitude. It is a cognitive bias that means that…

14Sep 2020 by ggarciadme@gmail.com

The KICS Principle (Keep It Competitive Stupid): an antidote to the “myopia” that slows down competitiveness

Competitive Assessment

By Raul Peralba, Markentry USA Partner Introduction This article is an adaptation made by the author from the introduction of his book, of the same title, written with Ralph Whitestone. It is currently available in Spanish via Amazon and will be published in English soon. The aeronautical engineer Clarence “Kelly” Leonard Johnson was a true innovator in the aerospace industry. He worked for many years at Lockheed Martin Skunk Works (secret projects department) and was highly regarded for his organizational skills and for dealing with highly complex matters. One of his biggest skills was the ability to break problems down and simplify them so that everybody involved in his projects was very clear about it all. I.e.: he recommended simple and understandable developments which could only cause errors that were…

15Jul 2020 by ggarciadme@gmail.com

10 keys for successful ‘networking’ of foreigners in the USA

Blog

By Gonzalo Garcia, Founder and CEO of Markentry USA Introduction Sonia Sotomayor, Justice of the US Supreme Court, was the first Hispanic to reach that position. As she said in her book 'My beloved World':Sometimes, idealistic people are put off the whole business of networking as something tainted by flattery and the pursuit of selfish advantage. But virtue in obscurity is rewarded only in Heaven. To succeed in this world you have to be known to people. I have just completed 18 years of professional career in the USA, 2 thirds of the total. During this time, I have continually faced the challenges encountered by people from different cultures and whose native language is not English. I have had the opportunity to deal with all kinds of people, including billionaire…

Tag: Business Development